Mimedx (MDXG) Net Income Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 60.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 19.97% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -52.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.85% |
| Sep 30, 2024 | 27.91% |
| Jun 30, 2024 | 26.04% |
| Mar 31, 2024 | 26.49% |
| Dec 31, 2023 | 28.71% |
| Sep 30, 2023 | 74.87% |
| Jun 30, 2023 | 1.66% |
| Mar 31, 2023 | 14.24% |
| Dec 31, 2022 | 49.10% |
| Sep 30, 2022 | -38.91% |
| Jun 30, 2022 | 14.21% |
| Mar 31, 2022 | 7.55% |
| Dec 31, 2021 | 26.11% |
| Sep 30, 2021 | -135.98% |
| Jun 30, 2021 | -44.00% |
| Mar 31, 2021 | -56.25% |
| Dec 31, 2020 | -55.62% |
| Sep 30, 2020 | -50.82% |
| Jun 30, 2020 | -50.24% |
| Mar 31, 2020 | -41.56% |
| Dec 31, 2019 | -7.00% |
| Sep 30, 2019 | 55.05% |
| Jun 30, 2019 | -120.45% |
| Mar 31, 2019 | -135.67% |
| Dec 31, 2018 | -67.60% |
| Sep 30, 2018 | -26.56% |
| Jun 30, 2018 | -30.74% |
| Mar 31, 2018 | 4.16% |
| Dec 31, 2017 | 34.72% |
| Sep 30, 2017 | 54.23% |
| Jun 30, 2017 | 160.12% |
| Mar 31, 2017 | 102.04% |
| Dec 31, 2016 | -62.32% |
| Sep 30, 2016 | 134.00% |
| Jun 30, 2016 | 66.40% |
| Mar 31, 2016 | 39.91% |
| Dec 31, 2015 | 117.79% |
| Sep 30, 2015 | 52.59% |
| Jun 30, 2015 | 110.28% |
| Mar 31, 2015 | 79.02% |
| Dec 31, 2014 | 51.65% |
| Sep 30, 2014 | 59.99% |
| Jun 30, 2014 | 46.19% |
| Mar 31, 2014 | 34.94% |